Header

Sub Navigation

Main Content

Article

Board of Podiatric Medicine

Notice: In response to COVID-19 and the impact it is having on the State of Indiana, the Professional Licensing Agency will have the majority of our staff working remotely in the coming weeks. While routine operations of the agency will continue, please note that there may be disruptions or delays in the processing of your requests. Please prioritize the usage of email to communicate with our staff whenever possible and scan any documents that need to be processed. We appreciate your patience and flexibility as we work best to protect our staff and serve Hoosiers in these ever-changing times.

Temporary Waiver from E-Prescribing Requirement: If a practitioner believes they may be eligible for a waiver from the e-prescribing requirements effective Jan. 1, 2021; they may visit the State Board of Pharmacy’s website to apply for a waiver. More information, including the reasons for which a waiver may be approved can be found HERE.

Important notice regarding changes to the law affecting Gabapentin and prescribing practitioners:

Effective July 1st, 2019, pursuant to House Enrolled Acts 1246 and 1542, the Indiana scheduled prescription electronic collection and tracking (INSPECT) program will begin monitoring and tracking the prescribing and dispensation of Gabapentin. Please note, this change solely provides for the monitoring and inclusion of Gabapentin in the INSPECT database and does not schedule or affect the prescribing of Gabapentin.

For more information and a copy of House Enrolled Act 1246 or House Enrolled Act 1542, please visit the Indiana General Assembly website at iga.in.gov.

 

Important notice regarding changes to the law affecting Continuing Education requirements for Controlled Substance Registrants and Re-registrants:

Effective July 1st, 2019, pursuant to Senate Enrolled Act 225-2018, a practitioner who is licensed by a board and applies for registration or re-registration to distribute or dispense a controlled substance must have completed two (2) hours of continuing education during the previous two (2) years addressing the topic of opioid prescribing and opioid abuse.

For more information and a copy of Senate Enrolled Act 225-2018, please visit the Indiana General Assembly website at iga.in.gov.

Please review the information below regarding on-going mandatory query laws:

  • Registration for the INSPECT database: IC 35-48-7-11.3
    • Beginning January 1, 2019, a practitioner who is permitted to distribute, dispense, prescribe, conduct research with respect to, or administer ephedrine, pseudoephedrine, or a controlled substance in the course of the practitioner's professional practice or research in the United States must be certified under section 11.1(d)(4) of this chapter to receive information from the INSPECT program.
  • Mandatory Query of the INSPECT database in certain instances: IC 35-48-7-11.1
    • Beginning July 1, 2018, A practitioner who has had the information from the database integrated into the patient's electronic health records.
    • Beginning January 1, 2019, a practitioner who provides services to the patient in the emergency department of a hospital licensed under IC 16-21 or  a pain management clinic.
    • Beginning January 1, 2020, a practitioner who provides services to the patient in a hospital licensed under IC 16-21.
    • Beginning January 1, 2021, all practitioners.

Senate Enrolled Act 221 is effective July 1st, 2018 with subsequent rolling effective dates for mandatory query when prescribing in certain circumstances.

The full text of the bill can be found at the following link: iga.in.gov

For more information or to sign up your facility for the Statewide Integration Initiative, visit the INSPECT website at the following address: https://www.in.gov/pla/inspect

Licensing Information

Effective immediately: Due to statutory requirements regarding processing times for application fees, the Indiana Professional Licensing Agency will no longer accept more than ten (10) fees per individual check for the application or renewal of a podiatry license.

If a check is received with more than ten (10) fees per check, it may result in the return of your check along with the applications or renewals to your program for correction.  Further delays in processing time, as a result of more than ten (10) fees per check, may also lead to potential late fees. We apologize for any inconvenience this may cause and appreciate your partnership as we continue to work together to issue licenses as quickly and efficiently as possible. 

If you have any questions regarding this matter, please email pla3@pla.in.gov.

Podiatrists
Limited License (Residency Training Permit) for Postgraduate Training Programs
Controlled Substance Registration
Verification of State Licensure Form

Resources

Criminal Background Check Information
License Renewal Information
Fee Schedule
Continuing Education Requirements
Name Change
Statutes and Rules
Board Approved Treatment Programs

Board Information

Members of the Board
Board Meeting Dates
Board Minutes & Agendas
Electronic Means of Participation Policy

Consumer Information

Consumer Complaint Process

Staff Information

Laura Turner, J.D., Board Director
Jody Edens, Acting Assistant Board Director
Christine Cowdin, Litigation Specialist
Elizabeth Sangar, Customer Service Representative
Meredith Shirley, Customer Service Representative
Zharia Collins, Customer Service Representative
Tiffany Finnell, Customer Service Representative

Phone Number: (317) 234-2060
Fax number: (317) 233-4236
Email Address: pla3@pla.in.gov

Indiana Professional Licensing Agency
Attn: Podiatry Board
402 West Washington Street, Room W072
Indianapolis, IN 46204